Hyperimmunoglobulinemia associated with narcotic addiction. Effects of methadone maintenance treatment.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001796:Blood Protein Disorders / Q000209:etiology*; D005260:Female; D006505:Hepatitis / Q000209:etiology; D006801:Humans; D005779:Immunodiffusion; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins; D008103:Liver Cirrhosis / Q000209:etiology; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D008875:Middle Aged; D009020:Morphine / Q000652:urine; D012709:Serum Albumin / Q000032:analysis; D019966:Substance-Related Disorders / Q000150:complications / Q000188:drug therapy / Q000276:immunology*
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D012709:Serum Albumin; D009020:Morphine; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001663:Bilirubin; D008691:Methadone